Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 1
1984 1
1985 1
1989 8
1990 1
1991 4
1992 4
1993 3
1994 2
1995 1
1996 1
1997 1
1999 1
2000 2
2001 1
2002 2
2005 1
2006 1
2007 4
2008 3
2009 4
2010 3
2011 4
2012 4
2013 6
2014 3
2015 7
2016 6
2017 4
2018 6
2019 2
2020 3
2021 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A, Cwynarski K, Mikhaeel G, Jerkeman M, Di Rocco A, Stepanishyna Y, Vitolo U, Santoro A, Re A, Puccini B, Olivieri J, Petrucci L, Barrington SF, Malkowski B, Metser U, Versari A, Chauvie S, Walewski J, Trneny M, Cavalli F, Gospodarowicz M, Johnson PWM, Davies A, Zucca E; International Extranodal Lymphoma Study Group (IELSG). Martelli M, et al. J Clin Oncol. 2024 Dec;42(34):4071-4083. doi: 10.1200/JCO-24-01373. Epub 2024 Aug 19. J Clin Oncol. 2024. PMID: 39159403 Clinical Trial.
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG). Ferreri AJM, et al. Among authors: angrilli f. Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17. Lancet Haematol. 2017. PMID: 29054815 Clinical Trial.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Stathis A, Pirosa MC, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FG, Merli F, Guièze R, Gyan E, Gini G, Marino D, Gressin R, Morschhauser F, Cavallo F, Palombi F, Conconi A, Tessoulin B, Tilly H, Zanni M, Cabras MG, Capochiani E, Califano C, Celli M, Pulsoni A, Angrilli F, Occhini U, Casasnovas RO, Cartron G, Devizzi L, Haioun C, Liberati AM, Houot R, Merli M, Pietrantuono G, Re F, Spina M, Landi F, Cavalli F, Bertoni F, Rossi D, Ielmini N, Borgo E, Luminari S, Zucca E, Thieblemont C. Stathis A, et al. Among authors: angrilli f. Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918. Haematologica. 2024. PMID: 38385243 Free PMC article. Clinical Trial.
Cometary science. The morphological diversity of comet 67P/Churyumov-Gerasimenko.
Thomas N, Sierks H, Barbieri C, Lamy PL, Rodrigo R, Rickman H, Koschny D, Keller HU, Agarwal J, A'Hearn MF, Angrilli F, Auger AT, Barucci MA, Bertaux JL, Bertini I, Besse S, Bodewits D, Cremonese G, Da Deppo V, Davidsson B, De Cecco M, Debei S, El-Maarry MR, Ferri F, Fornasier S, Fulle M, Giacomini L, Groussin O, Gutierrez PJ, Güttler C, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kramm JR, Kührt E, Küppers M, La Forgia F, Lara LM, Lazzarin M, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Mottola S, Naletto G, Oklay N, Pajola M, Pommerol A, Preusker F, Sabau L, Scholten F, Snodgrass C, Tubiana C, Vincent JB, Wenzel KP. Thomas N, et al. Among authors: angrilli f. Science. 2015 Jan 23;347(6220):aaa0440. doi: 10.1126/science.aaa0440. Science. 2015. PMID: 25613893
Cometary science. On the nucleus structure and activity of comet 67P/Churyumov-Gerasimenko.
Sierks H, Barbieri C, Lamy PL, Rodrigo R, Koschny D, Rickman H, Keller HU, Agarwal J, A'Hearn MF, Angrilli F, Auger AT, Barucci MA, Bertaux JL, Bertini I, Besse S, Bodewits D, Capanna C, Cremonese G, Da Deppo V, Davidsson B, Debei S, De Cecco M, Ferri F, Fornasier S, Fulle M, Gaskell R, Giacomini L, Groussin O, Gutierrez-Marques P, Gutiérrez PJ, Güttler C, Hoekzema N, Hviid SF, Ip WH, Jorda L, Knollenberg J, Kovacs G, Kramm JR, Kührt E, Küppers M, La Forgia F, Lara LM, Lazzarin M, Leyrat C, Lopez Moreno JJ, Magrin S, Marchi S, Marzari F, Massironi M, Michalik H, Moissl R, Mottola S, Naletto G, Oklay N, Pajola M, Pertile M, Preusker F, Sabau L, Scholten F, Snodgrass C, Thomas N, Tubiana C, Vincent JB, Wenzel KP, Zaccariotto M, Pätzold M. Sierks H, et al. Among authors: angrilli f. Science. 2015 Jan 23;347(6220):aaa1044. doi: 10.1126/science.aaa1044. Science. 2015. PMID: 25613897
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
Massaro F, Stepanishyna Y, Manni M, Luminari S, Galimberti S, Marcheselli L, Visco C, Tecchio C, Stelitano C, Angrilli F, Petrini M, Merli F, Federico M. Massaro F, et al. Among authors: angrilli f. Br J Haematol. 2021 Mar;192(6):1011-1014. doi: 10.1111/bjh.16714. Epub 2020 May 14. Br J Haematol. 2021. PMID: 32410259 Free article. Clinical Trial.
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.
Gentile M, Shanafelt TD, Cutrona G, Molica S, Tripepi G, Alvarez I, Mauro FR, Di Renzo N, Di Raimondo F, Vincelli I, Todoerti K, Matis S, Musolino C, Fabris S, Vigna E, Levato L, Zupo S, Angrilli F, Consoli U, Festini G, Longo G, Cortelezzi A, Arcari A, Federico M, Mannina D, Recchia AG, Neri A, Kay NE, Ferrarini M, Morabito F. Gentile M, et al. Among authors: angrilli f. Leukemia. 2016 Jun;30(6):1440-3. doi: 10.1038/leu.2015.333. Epub 2015 Dec 9. Leukemia. 2016. PMID: 26648537 No abstract available.
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.
Ambrosio MR, Lazzi S, Bello GL, Santi R, Porro LD, de Santi MM, Guazzo R, Mundo L, Rigacci L, Kovalchuck S, Onyango N, Fabbri A, Cencini E, Zinzani PL, Zaja F, Angrilli F, Stelitano C, Cabras MG, Spataro G, Bob R, Menter T, Granai M, Cevenini G, Naresh KN, Stein H, Sabattini E, Leoncini L. Ambrosio MR, et al. Among authors: angrilli f. Haematologica. 2019 Jan;104(1):e25-e28. doi: 10.3324/haematol.2018.195958. Epub 2018 Jun 28. Haematologica. 2019. PMID: 29954940 Free PMC article. No abstract available.
86 results